Memantine-related psychotic symptoms in a patient with bipolar disorder.
Canan
Fatih
F
Ataoglu
Ahmet
A
D000544:Alzheimer Disease / Q000188:drug therapy*; D018692:Antimanic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D000077265:Donepezil; D004347:Drug Interactions; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use / Q000633:toxicity*; D005260:Female; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D008559:Memantine / Q000627:therapeutic use / Q000633:toxicity*; D008875:Middle Aged; D018697:Nootropic Agents / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D011605:Psychoses, Substance-Induced / Q000175:diagnosis / Q000209:etiology*
D018692:Antimanic Agents; D018691:Excitatory Amino Acid Antagonists; D007189:Indans; D018697:Nootropic Agents; D010880:Piperidines; D000077265:Donepezil; D008559:Memantine